Inari Medical to Present at Upcoming Investor Conferences

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI) announced its participation in two upcoming investor conferences. The first is the Wells Fargo Healthcare Conference on September 9, 2022, at 8:35 a.m. Eastern Time in Boston, MA, featuring a fireside chat. The second is the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 8:10 a.m. Eastern Time in New York, NY, also a fireside chat. Interested parties can access live audio webcasts through the company’s website.

IRVINE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences:

• 2022 Wells Fargo Healthcare Conference
  Fireside chat on Friday, September 9, 2022, at 8:35 a.m. Eastern Time in Boston, MA.

• Morgan Stanley 20^th Annual Global Healthcare Conference
  Fireside chat on Monday, September 12, 2022, at 8:10 a.m. Eastern Time in New York, NY.

A live audio webcast and replay of the Wells Fargo and Morgan Stanley conference may be accessed on the “Investor Relations” section of the company’s website at: https://www.inarimedical.com/

About Inari Medical, Inc.
Inari Medical, Inc. is a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases. Our current product offering consists of two minimally invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by FDA and CE marked for the non-surgical removal of clot from peripheral blood vessels, including for the use in the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by FDA and CE marked for the non-surgical removal of clot from peripheral blood vessels, including for the use in the treatment of pulmonary embolism and clot in transit in the right atrium.

Investor Contact:
ICR Westwicke
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

What events is Inari Medical (NARI) participating in September 2022?

Inari Medical will present at the Wells Fargo Healthcare Conference on September 9 and the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022.

Where can I access the conference presentations for Inari Medical (NARI)?

Conference presentations can be accessed via the live audio webcast on Inari Medical's Investor Relations section of their website.

What time will Inari Medical's presentations occur during the investor conferences?

Inari Medical's fireside chat at the Wells Fargo Conference is at 8:35 a.m. ET, and at the Morgan Stanley Conference, it is at 8:10 a.m. ET.

What is the focus of Inari Medical as a company?

Inari Medical focuses on developing medical devices to treat patients with venous diseases, specifically targeting venous thromboembolism.